COH04S1 COVID-19 vaccine shown to produce robust antibodies and T cells against SARS-CoV-2
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc. (Nasdaq: GOVX), produced a robust neutralizing antibody and T cell (an immune cell) response against SARS-CoV-2 ...
Mar 10, 2022
0
51